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The role of the paravertebral muscles in
adolescent idiopathic scoliosis evaluated by
temporary paralysis
Christian Wong1* , Kasper Gosvig2 and Stig Sonne-Holm1
Abstract
Background: Muscle imbalance has been suggested as implicated in the pathology of adolescent idiopathic
scoliosis (AIS). The specific “pathomechanic” role of the paravertebral muscles as being scoliogenic (inducing
scoliosis) or counteracting scoliosis in the initial development and maintenance of this spinal deformity has yet to
be clarified in humans. In the present study, we investigated the radiographic changes of temporal paralysis using
botulinum toxin A as localized injection therapy (ITB) in the psoas major muscle in AIS patients.
Methods: Nine patients with AIS were injected one time with ITB using ultrasonic and EMG guidance in the
selected spine muscles. Radiographic and clinical examinations were performed before and 6 weeks after the
injection. Primary outcome parameters of radiological changes were analyzed using Wilcoxon signed-rank test and
binomial test, and secondary outcome parameters of short- and long-term clinical effects were obtained.
Results: Significant radiological corrective changes were seen in the frontal plane in the thoracic and lumbar spine
as well as significant derotational corrective change in the lumbar spine according to Cobb’s angle measurements
and to Nash and Moe’s classification, respectively. No serious adverse events were detected at follow-up.
Conclusions: In conclusion, this study demonstrated that the psoas major muscle do play a role into the pathology
in adolescent idiopathic scoliosis by maintaining the curvature of the lumbar spine and thoracic spine.
Trial registration: EudraCT number 2008-004584-19
Keywords: Injection therapy, Botulinum toxin A, Idiopathic scoliosis, Prospective study, Radiological Cobb’s angle
Background
The Greek physician Hippocrates was the first to describe
adolescent idiopathic scoliosis (AIS) as early as 400 BC
[1]. Today, the etiology of AIS is still considered multifac-
torial, even though over time many researchers have tried
to explain the pathology by one single etiology, ranging
from a broad variety of causes of either biomechanical or
genetic nature [2–6]. One relative recent observation by
Modi et al. is that the spinal deformity in mild AIS tries to
return to the neutral midline position, thereby displaying
a “wavy” curve pattern with fluctuations in a lateral curve
shape when followed closely [4]. They suggested that the
paravertebral muscles would have a “tuning/balancing
mechanism” that tries to correct the spinal deformity of
mild scoliosis into apparent spontaneous regression or to
prevent further progression of curve, and if failing, this
would result in further progression [4]. The natural his-
tory of AIS, where the majority spontaneously remains
stable while the rest either regresses or progresses, may be
seen as suggestive for this hypothesis [7], and the paraver-
tebral muscles or rather a misbalance of the paravertebral
muscles has been suggested as causative for progression
or regression of AIS [3, 4, 6, 8, 9]. Differences in morph-
ology examined by MRI, behavioral response to exercise,
and electromyographic response of the paravertebral
muscle have indicated that muscle imbalance may play a
role in the pathologic pathway that leads to progression or
regression of AIS. This important question of the “patho-
mechanic role” of paravertebral muscles is still debated
[10], but the evidence for the specific role as scoliogenic
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(inducing scoliosis) or counteracting scoliosis in human is
still circumstantial [2, 3, 9–13]. Recently, Grivas et al. ex-
amined this for the quadratus lumborum muscle by com-
paring the length of the 12th rib in a group of children
with right lumbar idiopathic scoliosis and straight spines;
he suggested that stimulation of the paravertebral muscles
should be performed to determine the “pathomechanic
role” in future studies [10]. In this study, we examined if
the hypnotized “pathomechanic role” of the psoas major
(PM) of the iliopsoas muscle is scoliogenic—not by stimu-
lation but by paralysis. The PM muscle is interesting for
examining the “pathomechanic role” for AIS; Bruggi et al.
found an interrelationship between the paravertebral
muscle iliopsoas and AIS, where the muscle in isometric
contraction had a corrective effect of the scoliotic curve
[14]. In addition, a volumetric asymmetry of the PM has
also been demonstrated in patients with degenerative AIS,
where hypertrophy of 6.3% on the convex side was con-
cluded to be associated with the scoliosis [12]. Yet, an-
other study was unable to demonstrate that this difference
had a significant effect in either the maximal voluntary
isometric contraction force between healthy girls (161.4
N) and girls with scoliosis (144.3 N) or in the strength of
the paravertebral muscle on either side of the scoliosis
[15]. This interest in the PM in regard to AIS stems from
the anatomy of the PM; it is a long fusiform muscle that is
distributed on the lateral side of the lumbar spine from
Th12 to L5, where it inserts on the transverse processes,
the two adjacent vertebral bodies and their intervertebral
discs. Moreover, it inserts from a series of tendinous
arches extending across the bodies of the lumbar verte-
brae. The PM then descends through the pelvic brim and
passes beneath the ligamentum inguinale. It is finally at-
tached to the trochanter minor of the femur. The function
of PM is that of having an antigravity compensation,
which also acts as a stabilizer of the lumbar lordosis in an
upright posture [16]. The hypnotized scoliogenic role of
the PM muscle would be that of initiating or maintaining
a lumbar scoliotic curvature by muscle contraction. The
PM would act by performing a lateral pull in the upper
part of the lumbar spine into a concave scoliotic curva-
ture, thus creating a convex thoracic curve in the thoracic
and thoracolumbar scoliosis. This is illustrated in Fig. 1.
The PM muscle would seem an ideal case in which to
examine and clarify this specific scoliogenic effect, since it
is of such a strength/magnitude/size that temporary par-
alysis would affect the scoliotic curves when recorded
radiographically and at the same time would be attainable
for safe percutaneous injection treatment.
Botulinum toxin A as a localized injection therapy
(ITB) has been utilized to reduce spasticity and improve
the motor dysfunction in cerebral palsy. ITB has already
been examined for neuromuscular scoliosis by injection
in the back muscles for treatment, where the corrective
and clinical efficacy was examined [17, 18]. However, to
our knowledge, ITB for AIS has not been investigated
Fig. 1 Schematic representation of the psoas major on the concave side of a thoracic scoliosis; C marks the stronger muscles on the thoracic
convex side scoliosis in accordance with the literature (left). Measurements of thoracic and lumbar Cobb’s angle and concave and convex rib
vertebra angle (right)
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and would seem to be ideal for examining the role of the
muscles in AIS, since it provides temporary muscle par-
alysis without long-term side effects or complications in
therapeutic doses in otherwise healthy humans [19]. In
this study, we conducted a small longitudinal prospect-
ive series using ITB for AIS, examining the radiological
changes when treatment would have maximal paralytic
effects (after 6 weeks). The purpose was to examine if
ITB would induce a change in curvature in AIS. This
could clarify if the spinal muscles play in the patho-
logical process of the AIS, whether the spinal muscles
would in fact induce the spinal deformity of AIS by the
muscle forces/pull of the PM, thus having a scoliogenic
effect, where regression of the AIS after paralysis would
happen.
Methods
In the present study, the patients were recruited patients
from those already being treated for AIS at our hospital
from the out-patient clinic. We carried out inclusion
after oral and written informed consent. Inclusion cri-
teria included a history of AIS, an age between 10 and
14 years, and a Cobb’s angle of at least 10°. Exclusion
criteria were hypersensitivity or allergy to botulinum
toxin A, ongoing infection at the injection sites, or prior
ITB within the last 6 months. The patients are charac-
terized clinically in Table 1.
The injection treatment was given as a standard dose
with three injections on the concave side of the lumbar
scoliosis in the PM part of the iliopsoas muscle, so that the
maximum dose in the single muscle did not exceed
100 units as in the earlier studies [17, 18]. After placement
of the injection needle in the target muscle, we confirmed
the correct placement by an ultrasound and by electric
simulation through the needle for correct identification of
the target muscle, since correct targeting of the deep back
muscles otherwise seemed unreliable [20]. An experienced
anesthesiologist and pediatric orthopedic surgeon per-
formed the injections under general anesthesia using pro-
pofol infusion and spontaneous breathing, when lying in
lateral position. We performed the radiographic examina-
tions before and 6 weeks after injection treatment with
standing radiographs, when botulinum toxin A would have
the maximum effect on the muscles (visit window of
2 weeks). The same staff performed the radiographic acqui-
sitions in a uniform, systematic manner, where patients
omitted the brace for 24 h before the acquisition [21]. The
primary outcome measures were the measurements of
Cobb’s angle for primary and secondary curves, and the
secondary parameters were the level of measurements for
primary and secondary curves, rib vertebra angles for the
thoracic apex vertebra, rib vertebrae angle difference, Nash
and Moe’s classification at the apex vertebrae of the primary
and secondary curves, and level of the apex vertebra for pri-
mary and secondary curves. Three experienced doctors per-
formed all measurements similarly, separately and blinded,
and we used the average results for further analyses. See
Fig. 1 for a schematic representation of the radiographic
evaluation.
Tertiary outcome measures were clinical, where pa-
tients and/or their parents were questioned openly at
follow-up after treatment and specifically about their/the
patient’s general well-being, about the effect of treatment
in regard to brace tolerance if any, about respiratory
problems, and about pain, endurance, and weight
change. The statistical analyses performed on the study
data were Wilcoxon signed-rank test (significance level
0.05) using SPSS (IBM Corp. released in 2013. IBM SPSS
Statistics for Windows, Version 22.0. Armonk, NY: IBM
Corp.) for measurements before and after ITB of Cobb’s
angle (primary parameter), rib vertebra angle, and rib
vertebrae angle difference and one sample binomial test
for change in the levels of apex vertebrae and levels of
curve measurements and Nash and Moe’s classification
Table 1 Patient characteristics
Pta 1 2 3 4 5 6 7 8 9
Ageb 14.5 (13.3) 14.0
(2.8)
13.5 (13) 11.9 (19) 10.4 (11) 8.44 (1) 12.5 (51) 11.7 (5.9) 14.6 (10.7)
Sexc fem fem fem fem fem male fem fem fem
Risser 0 4 0 0 1 2 4 4 4
Menad 0f 13.6 14.2 0e 11.6 0e 16 12.3 14.2
Type of scoliosisg Right TLS Right TS Right TLS Right TS Left TLS Right TLS Right TLS Right TLS Right TLS
Med. Cd BP + EDh SPH + CMh – – – BP – – BP
aPatient ID
bAge when diagnosed in years (time of injection after diagnosed in month)
cGender (fem female, male male)
dAge of menarche (years)
eBefore menarche
fNo menarche due to hormonal imbalance
gType of scoliosis (right right-handed, left left-handed, TLS S-shaped convex thoracolumbar scoliosis, TS thoracic scoliosis)
hMedical condition before injection (BP back pain, SPH physiological disorder of schizophrenia, ED eating disorder of anorexia, CM cyst in medulla)
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(significance level 0.05); if, in the Nash and Moe’s classi-
fication, the level of measurement of Cobb’s angle or
apex vertebrae changed with one, we considered this as
a change (+ 1), otherwise as no effect (0).
In this study, an off label medicine was used in chil-
dren and adolescents. We obtained appropriate permis-
sions from the Danish local ethical committee and the
Danish Health and Medicine Authority (EudraCT
number 2008-004584-19). The good clinical practice
unit of Copenhagen monitored this study, and we
screened the patients continuously for events, adverse
events, and serious adverse events throughout the study
period according to national guidelines, the European
GCP guidelines, and the Helsinki II Declaration for bio-
medical research involving humans. We received no
commercial or public financial support during the study.
Table 2 Radiological effects
Pt IDa 1 2 3 4 5 6 7 8 9 P valueb
cobb t prec 23.5(6.1) 38.7(8.1) 29.5(2.3) 12(19.6) 11.7(15.2) 18.6(14.0) 23(10.0) 31.1(17.0) 43.5(3.0)
cobb t postc 16.2(12.2) 33.3(8.1) 33.1(3.3) 3.8(6.4) 7.1(4.5) 7.3(11.7) 24.4(16.4) 33.3(15.5) 28.4(3.0) 0.015**
cobb l pred 40.9(7.3) 21(9.8) 11.6(13.8) 3.6(16.3) 22.7(9.6) 14.5(12.1) 16.5(12.0) 31.5(14.0) 41.8(10.4)
cobb l postd 37.3(5.4) 20.4(0.1) 12(1.4) 1(2.6) 26(6.8) 6.5(3.6) 18.8(1.7) 28.2(18.3) 39.1(3.2) 0.038**
RA conc pree 46.6 60.6 75.8 62.5 78.6 55.1 65.5 72.2 73.6
RA conc poste 73 64 65.8 58.6 64.4 56.4 78.5 68.6 75 0.953
RA conv pref 72.6 80.3 58.5 62.7 76.9 55.4 63.9 73.5 70.5
RA conv postf 69.7 69.4 54.5 69.6 83.2 63.4 58.6 61.1 69.1 0.594
RVAD preg − 26 − 19.7 17.3 − 0.2 1.7 − 0.3 1.6 − 1.3 3.1
RVAD postg 3.3 − 5.4 11.3 − 11 − 18.8 − 7 19.9 7.5 5.9 0.594
Pt IDh Pre Pt1 Post Pt1 Pre Pt2 Post Pt2 Pre Pt3 Post Pt3 Pre Pt4 Post Pt4 Pre Pt5 Post Pt5
TuppVi Th3 Th5 Th6 Th6 Th5 Th4 Th5 Th6 Th4 Th4
TlowV Th11 Th11 Th12 Th12 L1 L1 Th11 L3 Th11 Th11
ThoNMj 2 1 3 1 2 1 1 2 1 1
T apexk Th7 Th7 Th9 Th9 Th10 Th10 Th9 Th10 Th7 Th8
LuppV Th9 Th10 Th12 Th12 Th12 Th12 Th10 Th12 Th10 Th10
LlowV L4 L4 L4 L4 L4 L5 L4 L4 L4 L4
LumNM 3 2 3 1 2 1 1 1 3 1
L apex L1 L1 L2 L2 L2 L2 L1 L2 L2 L1
Pt IDh Pre Pt6 Post Pt6 Pre Pt7 Post Pt7 Pre Pt8 Post Pt8 Pre Pt9 Post Pt9 P valuel
TuppV Th1 Th1 Th7 Th4 Th4 Th5 Th5 Th5
TlowV L3 L4 Th12 Th12 Th12 Th12 Th11 Th12 0.508
ThoNM 1 1 2 2 2 1 2 1 0.201
T apex Th9 Th10 Th9 Th9 Th7 Th8 Th8 Th8 1.00
LuppV Th11 Th12 Th12 Th12 Th11 Th11 Th11 Th11
LlowV L4 L5 L4 L4 L4 L5 L4 L4 0.180
LumNM 1 1 1 1 2 1 3 2 0.023***
L apex L2 L3 L2 L2 L2 L2 L1 L2 1.00
aPre- and post-injection values for patient ID
bSignificance level after Wilcoxon signed-rank test (**significant at a level < 0.05)
cPre- and post-injection thoracic Cobb’s angle
dPre- and post-injection lumbar Cobb’s angle
ePre- and post-injection rib vertebrae angle on the concave side
fPre- and post-injection rib vertebrae angle on the convex side
gPre- and post-injection rib vertebrae angle difference
hPre- and post-injection values for patient ID
iUpper and lower levels for measurement of Cobbs angle (T thoracic, L lumbar)
jMeasurements of Nash and Moe’s classification (Tho thoracic, Lum lumbar)
kApex vertebra (T thoracic, L lumbar)
lSignificance level after Wilcoxon signed-rank test or binomial test (***significant at a level < 0.05)
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Results
Nine patients with AIS met the inclusion criteria. The
patients maintained prior treatment of physiotherapy,
bracing and otherwise throughout the study period. No
patients were excluded, lost at follow-up, or withdrew
from the study.
The primary outcome parameters with their subse-
quent statistical analyses are shown in Table 2. Figures 2
and 3 illustrate the changes of radiographic parameters
graphically and schematically.
Table 3 shows the clinical history of using brace treat-
ment and subsequent surgery, the ITB and the clinical
feedback throughout the study, where we noted remarks
from patients and parents after ITB by open questioning.
Two patients reported temporary soreness at the injec-
tion site, which regressed within days, and no other ser-
ious adverse events occurred during the study, except
for one patient who was injected in the erector spine
and quadratus lumborum as well as in the PM. No other
major medical or orthopedic surgical events at the time
of and after termination of the study; the subsequent
spinal surgeries took placed years after injection
treatment.
Discussion
The temporary muscular paralysis of the PM leads to
radiological changes in the spinal deformity of thoracol-
umbar AIS. These radiographic changes were a significant
improvement (lesser curve) in thoracic and lumbar Cobb’s
angle and a non-significant thoracic and significant lum-
bar derotation (changes in Nash and Moe’s classification),
and a non-significant small average change in rib vertebra
angles with an improvement on the convex side and a de-
terioration on the concave side. These changes were as ex-
pected better in the lumbar region, since the primary
effect is in the lumbar region, thus having subsequent less
change in the thoracic region as seen in Fig. 2. This im-
plies that the spine muscles do play a role in maintaining
the human adolescent idiopathic scoliosis by the muscle
contraction or pull by the PM, which was to be expected
if the muscle pull by contraction was released in the lum-
bar area with subsequent effect in the thoracic area as
hypnotized earlier. We prescribed the radiological changes
to the induced muscular paralysis due to the short follow-
up of 6 weeks, since all prior treatments were maintained
and no other clinical events occurred in the patient’s life.
A methodological obstacle of this study was to find an
adequate way of evaluating our radiographic results. In
clinical practice, a Cobb’s angle of at least in between 5°
and 10° would be a cutoff value of clinical radiographic
change [21]. The diurnal variation in Cobb’s angle for
AIS is 5° and the inter- and intra-observer variations are
7.2° and 4.9°, respectively [22]. In this study, we would
expect subtle smaller radiographic changes, due to ITB
which induces only partial reduction of muscle function
[23, 24], and seen in this perspective, we would not
Fig. 2 Changes in radiographic parameters. To the left: dark green, significant improvement in Cobb’s angle (curves) and Nash and Moe’s
classification (error); light green, insignificant improvement in Nash and Moe’s classification (error) and in rib vertebra angle (line); red, insignificant
deterioration in rib vertebra angle (line). To the middle and right: an example of pre- (middle) and post-injection (right) radiographs for patient
number 9, where there is a smaller lumbar Cobb’s angle and larger thoracic Cobb’s angle after injection of botulinum toxin A
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expect to detect radiological changes as high as clinical
cutoff values [18]. Moreover, three patients had main
thoracic curves (patients 3, 4, and 7), and we would ex-
pect lesser effect (as in fact seen) than if all patients had
main lumbar curves. Additionally, our intra-observer
variation for Cobb’s angle was high (average SD of 9.1°)
in spite of trying to minimize measuring error by using
three blinded experienced doctors and achieve higher
accuracy in our radiological recordings by a standardized
standing radiographic protocol. For these reasons, we
used nonparametric statistical analyses of Wilcoxon
signed-rank and one sample binomial test, in which the
clinical cutoff value was not included.
In this study, the role of the PM muscle in humans
would be scoliogenic, which maintains AIS, but this con-
clusion can probably not be extrapolated to all of the
paravertebral muscles in general. However, to our
knowledge, this is the first study in the paravertebral
muscles that are influenced directly by the immediate
temporary paralysis in humans in order to examine the
role in AIS, which in our view is being an important step
for the further exploration and understanding of the eti-
ology of AIS. We would recommend to examine this by
stimulation instead of paralysis for future studies as sug-
gested by Grivas et al. [10]. Our above-described radio-
graphic changes may be seen as mimicking a “wavy
pattern” as described earlier [4], where slight changes in
level and size occurred as a response to the almost imme-
diate paralysis of the PM muscle. However, if bilateral par-
alyses were performed instead of unilateral, this might
have resulted in larger changes and have shed light on the
role of the paravertebral muscles even further, but bilateral
paralysis was omitted for safety reasons to minimize
botulinum toxin dosage for the patients to prevent
Fig. 3 Changes in radiographic parameters: patient number on the ordinal axis (x) and Cobb’s angle on the vertical axis (y): yellow = Cobb’s
angle pre-injection in the thoracic spine, red = Cobb’s angle post-injection in the thoracic spine, green = Cobb’s angle pre-injection in the lumbar
spine, and blue = Cobb’s angle post-injection in the lumbar spine
Table 3 Clinical treatment and Experimental injections
Pt. *1 1 2 3 4 5 6 7 8 9
Brace*2 Prov Prov Prov 0 Prov 0 Prov Prov Prov
IniBra*3 7.6 6.3 3.0 6 26.5 16.4 9.3
TermBra*4 52.4 21.7*5 51.8 28*6 67.9 42.7 31.7
TInj*7 10.7 2.87 13.45 11.94 1 10.4 51.2 5.9 13.37
IDose*8 100 100 100 100 100 100 100 100 420
TMusc*9 IP dex IP dex IP dex IP dex IP dex IP dex IP dex IP dex IPQE
Med. E*10 S, TBP – – – – NBP – – S, NBP
Surg. E – SU *13 SU *13 SU *13 cancelled SU*12 SU *14 – – –
*1 Patient ID *2 Type of Brace (Prov = Providence brace, 0 = no brace) *3 treated with Brace from time of diagnosis - initiation (months) *4 treated with brace
from time of diagnosis - termination (months) *5 Brace abandoned due to physiological disorder of schizophrenia *6 omit brace treatment due to discomfort and
psychological reasons *7 treated with injection from time of diagnosis (months) *8 Injection dose (Allergan units) *9 Injection in target muscles (IP = Iliopsoas,
IPQE = Iliopsoas, quadratus lumborum and erector spinae, dex = right side, sin = left side) *10 clinical effects or adverse events after injection (S = soreness, NBP = no
effect on back pain, TBP = temporary effect on back pain) * 11 surgical history at a later stage (SU = Spinal corrective surgery) *12 Su cancelled due to eating disorder
and hormone treatment *13 correction at level Th4-L1 ad modem K2 M *14 correction at level Th3-L2 ad modem MESA Range + removal of cyst in medulla
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systemic spread, and ethical approval was only for unilat-
eral treatment. Moreover, studies using electromyography
and/or magnetic resonance imaging for muscle volume
and muscle quality (fatty infiltration) indicate that the
spinal muscles are significantly stronger and larger on the
convex side at the apex of the curve of the scoliosis [9, 11,
25, 26]; this would indicate that ITB of the paravertebral
muscles would have a correcting effect, when injected on
the convex side. At the initiation of this study, we evalu-
ated that the muscle contraction/pull of PM on the con-
cave side of the lumbar curve of the thoracolumbar
scoliosis in fact brought about the deformity as seen in
Fig. 1. In retrospect, the ITB should have been performed
either on the convex side or bilaterally, and this could be
undertaken in a future study, if another study using ITB in
humans was to be undertaken. Our suggestion would be
to focus on primary lumbar curves, since the radiological
effects were more pronounced in this region. Also, the
multifidi and quadratus lumborum muscles have been ex-
amined as potential scoliogenic muscles and could be of
interest for future studies [10, 27].
The ethical motivation to perform such a study in
humans should be discussed. Firstly, our primary ethical
motivation for initiating this experimental study was to
discover a potential effective corrective or clinical bene-
ficial treatment for AIS. This should be performed
strenuously protocolled experimental and monitored
study as in this study. The window for effective ITB
treatment for AIS would be in the small curve AIS as a
supplement for our current conservative treatment of
bracing. This might have been able to alleviate humans
with brace-treated AIS, since it currently is strenuous
and with low compliance to follow [28–30]. From this
point of view, it would seem inappropriate not to look
for alternate treatment strategies and it certainly would
be attractive to find an alternative treatment or to sup-
plement the current conservative treatment. This was
our motivation for initiating this study, namely, to inves-
tigate if using ITB to treat AIS would lead to improve-
ment of curve and stop curve progression for affected
humans. This radiological corrective effect was plausible
since we supposedly addressed the culprit of the potential
pathology, namely, the PM muscle of the back. However,
we did not find radiological corrective effect or patient-
reported benefits to a convincing clinical level in our
population of patients with AIS—even though radiological
correction of significant magnitudes was achieved. We
expected that it would be less stressful for the patients when
wearing a corrective brace, but we did not find such an
effect. In the aftermath of the study, five patients were
candidates for surgery, which would suggest that the long-
term effect of ITB was not seen. The ITB was in our evalu-
ation unrelated to surgery, since these were performed
several years later and ITB have an expected effect of
3 months and severe deterioration after ITB was not seen.
However, since we were unable to detect a coherent clinical
or corrective treatment for short-term effects, we decided
not to perform a second injection in any of the patients in
an “interim” analysis after inclusion after the ninth patient.
Conclusions
In conclusion, this study demonstrated that the paraver-
tebral muscle psoas major do play a role in the path-
ology in maintaining adolescent idiopathic scoliosis, and
this role is maintaining the curvature of the lumbar
spine primarily and affecting the curvature of the
thoracic spine secondarily.
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